Osborne Clarke has advised Grifols on the deal. Grifols signed an agreement with the Hong Kong’s Tiancheng International Investment Ltd. to acquire 100% of the shares...
You must be a Standard 1 Year member to access this content.
Osborne Clarke and Proskauer advised Grifols on the deal, while Dechert advised GIC. As part of the transaction, GIC will become a strategic investor in Grifols’...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of seven U.S. plasma donation centres from Kedrion for USD 55.2 million. The operation received regulatory...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Grifols on the deal. Grifols executed the acquisition of remaining 56 per cent share capital in GigaGen Inc., for USD 80 million. GigaGen is a...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Grifols on the deal while Greenberg Traurig, LLP represented Tiancheng Investment Management and its portfolio company Bio Products Laboratory. Grifols executed the $370...
You must be a Standard 1 Year member to access this content.
Proskauer and JunHe advised Grifols in its alliance with Shanghai RAAS. Grandway Law Offices advised the seller. Pursuant to the transaction, Grifols S.A. (NASDAQ: GRFS) will exchange...
You must be a Standard 1 Year member to access this content.
